TY - JOUR
T1 - A randomized open-label phase III trial evaluating the addition of denosumab to standard first-line treatment in advanced NSCLC : the European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR trial
JO - Journal of Thoracic Oncology
UR - http://eprints.whiterose.ac.uk/163844/
PY - 2020/06/18
AU - Peters S
AU - Danson S
AU - Hasan B
AU - Dafni U
AU - Reinmuth N
AU - Majem M
AU - Tournoy KG
AU - Mark MT
AU - Pless M
AU - Cobo M
AU - Rodriguez-Abreu D et al
ED -
DO - DOI: 10.1016/j.jtho.2020.06.011
PB - Elsevier
Y2 - 2025/07/17
ER -